InvestorsHub Logo
Followers 2
Posts 1007
Boards Moderated 0
Alias Born 05/15/2009

Re: None

Sunday, 08/13/2017 1:03:00 PM

Sunday, August 13, 2017 1:03:00 PM

Post# of 108192
we should see some announcement about MINE phase 1 patient dosing very soon..i expect it will concentrate on cancer sub types which express multiple genetic markers for lm vector to target as there appears to be a correlation between efficacy and number of identified targets on the expressing sub types..i believe HOT was engineered with two sub types in mind for cervical after examination of GOG phase 2 trial results....a very very exciting time for immuno herapy in general and adxs in particular..
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News